(MUMBAI) Daiichi Sankyo's US$4.6 billion bid for control of India's Ranbaxy Laboratories Ltd could be the trigger for foreign pharmaceutical companies to step up the hunt for low-cost Indian drug makers for fear of being left behind.
Sunday, June 15, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment